Albrechtsenvalentine2747
Although ZnO NPs exhibited higher toxicity, as indicated by the NRRT50 values, both NPs affected similarly a wide range of the cellular parameters mentioned above. The latter parameters could constitute sensitive biomarkers in biomonitoring studies of terrestrial environment against nanoparticles.Clotrimazole (CLO) is an imidazole fungicide used in human and veterinary medicine for treating fungal infection. This study evaluated the changes in morphological, haematological and biochemical indices in Clarias gariepinus juveniles exposed to CLO. After the acute exposure, the 96 h LC50 value of CLO determined by probit analysis was 38.79 mgl-1. Based on this value, fish were exposed to sublethal concentrations of 7.76, 3.89, 1.94 and 0.00 mgl-1 (control) of CLO for 21 days and were allowed to recover for 7 days. The result revealed no significant effect on the hepatosomatic index and condition factor of the exposed fish. There were concentration and time-dependent significant decreases in red blood cell (RBC), haemoglobin (Hb), packed cell volume (PCV) and mean corpuscular volume (MCV) with significant increase in the white blood cell (WBC), mean corpuscular haemoglobin concentration (MCHC), and mean corpuscular haemoglobin (MCH) in the exposed group when compared with the control. A mixed trend was observed in the levels of neutrophils, lymphocytes, monocytes and eosinophils. The levels of alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP) and glucose values significantly increased, while protein levels were reduced (p less then 0.05) throughout the 21-day exposure and the 7-day recovery period. The present research indicated that CLO may have potential toxic effect on non-target organisms especially fish and, therefore, should be monitored in the aquatic ecosystem.The role of metal speciation on metal bioavailability, bio-reactivity and toxicity at the fish intestine is poorly understood. To investigate these processes, we used an in vitro model of the rainbow trout (Oncorhynchus mykiss) intestine, the RTgutGC cell line. Cells were exposed to two essential metals (copper and zinc) and two non-essential metals (cadmium and silver) in a medium of well-defined composition, which allowed the determination of metal speciation in solution. Concentrations resulting in a 50% cell viability reduction (EC50) were measured using a viability assay based on two endpoints metabolic activity and membrane integrity. Metal bioavailability and bio-reactivity was studied at non-toxic (300 nM all metals) and toxic (EC10; Ag-0.6, Cu-0.9, Cd-3, and Zn-9 μM) concentrations. Bioavailability (i.e. intracellular metal accumulation) was determined by ICP-MS, while bio-reactivity (i.e. induction of a metal specific transcriptional response) was determined by measuring the mRNA levels of a known biomarker of metal exposure (i.e. metallothionein) and of copper and zinc transporters (i.e. ATP7A and ZnT1). Dominant metal species in the exposure medium were Zn2+, CuHPO4, CdCl+, and AgCl2- respectively for Zn, Cu, Cd, and Ag. The EC50s showed the metal toxicity hierarchy Ag > Cu > Cd > Zn. In RTgutGC cells, essential metal homeostasis was tightly regulated while non-essential metals accumulated more readily. Non-essential metals were also more bio-reactive inducing higher MT and ZnT1 mRNA levels. Taken together these findings indicate that metal toxicity in RTgutGC cannot solely be explained by extracellular metal speciation but requires the evaluation of metal bioavailability and bio-reactivity.Background Low muscle strength (dynapenia) is a primary characteristic of sarcopenia, the age-related loss of muscle mass and strength or low walking speed. New evidence suggests that muscle strength positively affects blood pressure (BP) responses to exercise. As older adults with lowest handgrip strength also have lowest BP at rest, those with dynapenia may experience attenuated BP responses during physical activity. The purpose of this study was to test the hypothesis that dynapenic older adults would exhibit lower BP response to post-exercise muscle ischemia (PEMI). Methods Brachial and aortic systolic BP (SBP), diastolic BP (DBP), and mean arterial pressure (MAP) were measured in older adults (age, 80 ± 5 y) with dynapenia (n = 16) and non-dynapenia (n = 9) at rest and during PEMI following 2 min of isometric handgrip exercise at 30% maximal voluntary contraction. Walking speed was assessed by an 8-foot (2.44 m) walk course. Results Increases in aortic SBP (11 ± 2 vs. 23 ± 6 mm Hg, p = .03), DBP (6 ± 2 vs.14 ± 4 mm Hg, p = .04), and MAP (8 ± 1 vs. 17 ± 5 mm Hg, p = .02) were lower in dynapenic compared to non-dynapenic adults. Aortic MAP (r = 0.52, p less then .05) response to PEMI was correlated with MVC in dynapenic adults. Gait speed was correlated with aortic DBP response to PEMI (r = 0.698, p = .05) in non-dynapenic adults. Conclusions Our findings indicate that aortic DBP response to muscle metaboreflex activation is attenuated in older adults with dynapenia. MYCMI-6 nmr Normal aortic DBP response during metaboreflex activation may positively affect walking performance in non-dynapenic older adults.Alcohol-related brain injury (ARBI) is an unrecognised and therefore untreated consequence of alcohol use disorder. Here, we explore 12-month period prevalence of alcohol-related brain injury (ARBI) in alcohol use disorder patients. Inpatients aged ≥18 years reviewed by the Alcohol Care Team's Specialist Nurses between 1 April 2017 and 31 March 2018 were eligible for the study (n=1276). Screening identified a high-risk subset of patients who matched at least one of the following 1) more than three alcohol-related admissions in one year; 2) two alcohol related admissions in any given 30-day period; 3) patient or their significant other had concerns regarding cognition. The high-risk patients were assessed for evidence of ARBI using the Montreal Cognitive Assessment Tool (MoCA). The primary measure of interest was MoCA ≤23. Analysis was conducted between subgroups of the study population to identify prevalence rate ratios for matching the high-risk screening criteria, and MoCA ≤23 in high-risk patients. 205 patients were identified as high risk for ARBI.